报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 8.37% | 54.71% | 50% | 28/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 5.58% | 69.09% | 105.15% | 28/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 2.72% | 51.11% | -58.91% | 35/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 6.62% | -69.67% | 22.37% | 60/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 5.41% | -72.75% | 63.94% | 56/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 3.3% | -75.86% | 83.33% | 64/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 1.8% | -72.77% | -91.75% | 66/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 21.83% | -7.03% | 9.97% | 21/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 19.85% | -1.93% | 45.21% | 22/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 13.67% | 8.32% | 106.81% | 21/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 6.61% | 3.93% | -71.85% | 21/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 23.48% | -27.71% | 16.01% | 30/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 20.24% | -38.33% | 60.38% | 26/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 12.62% | -32.87% | 98.43% | 35/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 6.36% | 2% | -80.42% | 26/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 32.48% | 6.42% | -1.04% | 25/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | 32.82% | 2% | 74.57% | 14/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-06-30 | 18.8% | 39.67% | -38.4% | 22/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
2019-12-31 | 30.52% | 8.92% | 126.75% | 14/129 | 14.38% | 圣湘生物 | 29.33% | 行业排名> |
2019-06-30 | 13.46% | 2% | -51.96% | 11/129 | 6.73% | 健尔康 | 84.09% | 行业排名> |
2018-12-31 | 28.02% | -13.44% | -13.44% | 20/129 | 12.98% | 祥生医疗 | 28.56% | 行业排名> |
2017-12-31 | 32.37% | 2% | 2% | 9/129 | 13.82% | 心脉医疗 | 31.04% | 行业排名> |